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We appreciate the kind comments from Dr FA Shiekh and 
his evaluation of our recent paper on nano-engineered 
drug-releasing Ti wires as an alternative for local delivery 
of chemotherapeutics in brain.1 We enjoyed reading his 
comments and are pleased to hear his appreciation for new 
approaches outside conventional drug therapy aiming to 
address blood–brain barrier issues, certainly one of the most 
important problems in modern neurobiology. Nanotechnology 
approaches certainly offer considerable potential for designing 
new drug delivery systems and exciting developments will 
come in the near future. Nano-engineered drug-releasing 
devices for local drug delivery based on titania nanotube 
(TNT) arrays are a promising example that provide several 
advantages, which we highlighted in our paper.
In our work we presented initial in vitro studies using 
two model drugs, relevant CNS, and brain therapy to 
demonstrate the potential application of TNT/Ti wires as 
drug-releasing implants, and we also noted that extensive in 
vivo investigations are necessary in the future to prove the 
performance of these implants. Although we didn’t provide 
direct experimental evidence, previous studies successfully 
demonstrated the application and biocompatibility of TNT/
Ti in animals2 and in vivo conditions.3 In our recent work 
(Aw et al, unpublished data, 2012) using an ex vivo bone 
model, we developed a method to measure drug release 
kinetics from TNT/Ti wire inserted inside bone and to 
monitor drug distribution in bone. We propose that TNT/Ti 
wire implants could be inserted via a microsurgery inside 
or close to the target area of the brain where treatment is 
required. The invasiveness of TNT/Ti wire implants remains 
a disadvantage, even though the implantation of thin wires 
(0.5 mm diameter) is less invasive in comparison with other 
brain implants (polymer discs, 2 cm diameter).  However, 
this limitation can only be addressed once in vivo studies 
have been  performed. Nevertheless, we believe the potential 
benefits of this system for providing localized therapeutic 
effectiveness and bypassing the blood–brain barrier without 
systemic drug distribution is significant.
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